NIH-funded research R01 grant

Virtual care for opioid use disorder

Official title: Telemedicine for Treatment of Opioid Use Disorder

Funded at Harvard Medical School · NIH-11173855 · Data updated 2026-11-12

This project looks at how virtual (video or phone) treatment and pharmacy dispensing affect access to buprenorphine for adults with opioid use disorder.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 1, 2019
Project endMay 31, 2028
Funding year2025
Award (this year)$748,958
NIH project number5R01DA048533-06
Project IDNIH-11173855 on NIH RePORTER

Who could benefit from this research

Could help

Adults with opioid use disorder, especially those receiving care covered by Medicare, Medicaid, or commercial insurance, are the most relevant group.

Less likely to help

People under 21, the uninsured, or patients whose prescriptions aren't captured in the national pharmacy data may not be represented or benefit directly from this project.

What this research studies

If I have opioid use disorder, this project uses national insurance and pharmacy records to see how people get care by video, phone, or in person. The team will compare patients treated by clinicians who provide fully virtual care with those treated by other clinicians and will study whether audio-only (phone) visits work as well as video. They will also track how many pharmacies dispense buprenorphine and whether pharmacy decisions affect patient outcomes. The work draws on Medicare, Medicaid, commercial claims, and national pharmacy data to analyze large numbers of real-world patients.

Why it matters

Potential benefit: If successful, this work could make it easier to access buprenorphine via telehealth and help shape policies that expand safe treatment options.

How similar studies have gone: Prior work from this team and others, including 24 published papers from the first funding period, has documented tele‑OUD growth and quality questions, and this renewal builds on that evidence while addressing remaining gaps.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Huskamp, Haiden a. — Harvard Medical School
  • Study coordinator: Huskamp, Haiden a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.